Infanrix-IPV

Infanrix-IPV Dosage/Direction for Use

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Dosage/Direction for Use
Posology: The primary vaccination schedule consists of three doses in the first year of life and can start from the age of 2 months. An interval of at least 1 month should be respected between subsequent doses.
When the primary course is completed before the age of 6 months, a booster dose can be given in the second year of life. An interval of at least 6 months after completion of primary vaccination schedule should be respected. Data on the use of the vaccine as a booster has been obtained for children up to the age of 13 years.
Infanrix-IPV should be used in accordance with available official recommendations.
Method of administration: Infanrix-IPV is for deep intramuscular injection. For infants, the preferred site of injection is the anterolateral aspect of the thigh; in older children, vaccine should be administered in the deltoid.
It is preferable that each subsequent dose is given at alternate sites.
Infanrix-IPV should be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramascular administration to these subjects. Firm pressure should be applied to the injection site (without rubbing) for at least two minutes.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in